OGN Organon & Co

  1. Stocks
  2. Healthcare
  3. NYSE: OGN

Price (delayed)

$13.85

Market cap

$3.64B

P/E Ratio

17.31

Dividend/share

$0.08

EPS

$0.8

Enterprise value

$10.74B

?
Relative Growth: Rel. Growth: 13
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 76
Relative Profitability: Rel. Profitability: 58
Highlights
The quick ratio has grown by 39% YoY and by 11% from the previous quarter
The equity is up by 32% YoY and by 19% QoQ
The price to earnings (P/E) is 140% more than the 5-year quarterly average of 7.2 and 36% more than the last 4 quarters average of 12.7
The company's EPS has shrunk by 59% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Peers: OPK ORGO

Key stats

What are the main financial stats of OGN

OGN stock price

How has the Organon stock price performed over time
Intraday
0.22%
1 week
0.73%
1 month
0.95%
1 year
106.41%
YTD
93.17%
QTD
1.09%

Financial performance

How have Organon's revenue and profit performed over time
Revenue
$6.1B
Gross profit
$3.24B
Operating income
$831M
Net income
$213M
Gross margin
53.1%
Net margin
3.5%
Organon's net income has plunged by 57% YoY
Organon's net margin has plunged by 56% YoY but it has increased by 2.9% from the previous quarter
The company's operating income fell by 31% YoY
OGN's operating margin is down by 29% year-on-year

Price vs fundamentals

How does OGN's price correlate with its fundamentals

Growth

What is Organon's growth rate over time

Valuation

What is Organon stock price valuation
OGN P/E details
P/E
17.31
P/B
3.05
P/S
0.6
EV/EBIT
11.31
EV/EBITDA
8.3
EV/Sales
1.76
The price to earnings (P/E) is 140% more than the 5-year quarterly average of 7.2 and 36% more than the last 4 quarters average of 12.7
The company's EPS has shrunk by 59% YoY
The equity is up by 32% YoY and by 19% QoQ
The P/B is 13% more than the last 4 quarters average of 2.7
The price to sales (P/S) is 50% higher than the last 4 quarters average of 0.4 but 25% lower than the 5-year quarterly average of 0.8
The revenue has declined by 3.2% year-on-year

Efficiency

How efficient is Organon business performance
The return on equity has dropped by 71% year-on-year and by 6% since the previous quarter
The ROA has dropped by 58% year-on-year
The return on invested capital has declined by 22% year-on-year
The company's return on sales fell by 19% YoY

Dividends

What is OGN's dividend history
Dividend details
DPS
$0.08
Dividend yield
0.58%
Payout ratio
10%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Organon financials performed over time
OGN's total assets is 10% more than its total liabilities
The quick ratio has grown by 39% YoY and by 11% from the previous quarter
OGN's current ratio is up by 15% year-on-year and by 3.6% since the previous quarter
The equity is up by 32% YoY and by 19% QoQ
The debt to equity has contracted by 26% YoY and by 16% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.